Cargando…
Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
One hundred and forty-two patients with Hodgkin's disease PS I or II were treated with total or subtotal nodal irradiation as part of a prospective randomized trial in the Danish National Hodgkin Study during the period 1971-83. They were followed till death or--at the time of this analysis--fr...
Autores principales: | Specht, L., Nordentoft, A. M., Cold, S., Clausen, N. T., Nissen, N. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001736/ https://www.ncbi.nlm.nih.gov/pubmed/3300762 |
Ejemplares similares
-
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pinochet, Pierre, et al.
Publicado: (2021) -
The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014) -
Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.
por: Leonard, R. C., et al.
Publicado: (1983) -
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
por: Martynchyk, Arina, et al.
Publicado: (2023) -
Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
por: Yeoh, Kheng-Wei, et al.
Publicado: (2011)